Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion for Binge Eating Disorder
NCT00414167Phase 3Completed
- Sponsor
- Yale University
- Start
- Dec 2005
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bupropion in binge eating disorder (BED), sponsored by Yale University. Started Dec 2005; status: completed.
02
Drugs
bupropion
03
Conditions
binge eating disorder (BED)
Beyond the preview
Go deeper on NCT00414167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00414167.